Medical Professionalism

  • David J. Rothman, David Blumenthal, George E. Thibault. Medicial Professionalism In An Organizational Age: Challenges And Opportunities. Health Affairs. 2020;39(1):108-114. doi:
  • Adam Bonica, Howard Rosenthal, David J. Rothman. The Political Polarization of Physicians in the United States: An Analysis of Campaign Contributions to Federal Elections, 1991 Through 2012. JAMA Intern Med. 2014;174(8):1308–1317. doi:
  • David Schleifer and David J. Rothman. “‘The Ultimate Decision Is Yours’: Exploring Patients’ Attitudes about the Overuse of Medical Interventions.” PLOS ONE, vol. 7, no. 12, Dec. 2012, p. e52552. PLoS Journals, doi:10.1371/journal.pone.0052552.
  • David J. Rothman and David Blumenthal. Medical Professionalism in the New Information Age. New Brunswick: Rutgers University Press, 2010.
  • Sheila M. Rothman; David J. Rothman. 2009. “Marketing HPV Vaccine: Implications for Adolescent Health and Medical Professionalism.” JAMA 302 (7): 781–86.
  • Janlori Goldman; Sydney Kinnear; Jeannie Chung; David J. Rothman. 2008. “New York City’s Initiatives on Diabetes and HIV/AIDS: Implications for Patient Care, Public Health, and Medical Professionalism.” American Journal of Public Health 98 (5): 807–13.

Conflict of Interest

  • Susan Chimonas, Nicholas J. DeVito & David J. Rothman (2017) Powered by Sunshine: Next Steps for Making Transparency Matter, The American Journal of Bioethics, 17:6, W1-W2, DOI: 10.1080/15265161.2017.1324584
  • David J. Rothman, Professional Medical Associations and Divestiture from Industry: An Ethical Imperative for Pain Society Leadership, Pain Medicine, Volume 17, Issue 2, February 2016, Pages 218–219,
  • Sheila M. Rothman, Karen F. Brudney, Whitney Adair, David J. Rothman. Medical Communication Companies and Industry Grants. JAMA. 2013;310(23):2554–2558. doi:
  • Susan Chimonas; Susanna D. Evarts; Sarah K. Littlehale; David J. Rothman. 2013. “Managing Conflicts of Interest in Clinical Care: The ‘Race to the Middle’ at U.S. Medical Schools.” Academic Medicine: Journal of the Association of American Medical Colleges 88 (10): 1464–70.
  • Susan Chimonas; Frederica Stahl; David J. Rothman, “Exposing Conflict of Interest in Psychiatry: Does Transparency Matter?” International Journal of Law and Psychiatry, vol. 35, no. 5–6, Dec. 2012, pp. 490–95. PubMed, doi:10.1016/j.ijlp.2012.09.009.
  • David J. Rothman “Consequences of Industry Relationships for Public Health and Medicine.” American Journal of Public Health, vol. 102, no. 1, Jan. 2012, p. 55. PubMed Central, doi:10.2105/AJPH.2011.300507.
  • Susan Chimonas; Zachary Frosch; David J. Rothman. “From Disclosure to Transparency: The Use of Company Payment Data.” Archives of Internal Medicine 171, no. 1 (January 10, 2011): 81–86.
  • Sheila M. Rothman; Victoria H. Raveis; Anne Friedman; David J. Rothman. 2011. “Health Advocacy Organizations and the Pharmaceutical Industry: An Analysis of Disclosure Practices.” American Journal of Public Health 101 (4): 602–9.
  • Susan Chimonas; Lisa Patterson; Victoria H. Raveis; David J. Rothman. 2011. “Managing Conflicts of Interest in Clinical Care: A National Survey of Policies at U.S. Medical Schools.” Academic Medicine: Journal of the Association of American Medical Colleges 86 (3): 293–99.
  • David J. Rothman; Walter J. McDonald; Carol D. Berkowitz; Susan Chimonas; Catherine D. DeAngelis; Ralph W. Hale; Steven E. Nissen, et al. 2009. “Professional Medical Associations and Their Relationships with Industry: A Proposal for Controlling Conflict of Interest.” JAMA 301 (13): 1367–72.
  • David J. Rothman; Susan Chimonas. 2008. “New Developments in Managing Physician-Industry Relationships.” JAMA 300 (9): 1067–69.
  • David J. Rothman. 2008. “Academic Medical Centers and Financial Conflicts of Interest.” JAMA 299 (6): 695–97.
  • Susan Chimonas; Troyen A. Brennan; David J. Rothman. 2007. “Physicians and Drug Representatives: Exploring the Dynamics of the Relationship.” Journal of General Internal Medicine 22 (2): 184–90.
  • Troyen A. Brennan; David J. Rothman; Linda Blank; David Blumenthal; Susan C. Chimonas; Jordan J. Cohen; Janlori Goldman, et al. 2006. “Health Industry Practices That Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers.” JAMA 295 (4): 429–33.
  • Susan Chimonas; David J. Rothman. 2005. “New Federal Guidelines For Physician–Pharmaceutical Industry Relations: The Politics Of Policy Formation.” Health Affairs 24 (4): 949–60.

Physician Advocacy

  • Adam Bonica, Howard Rosenthal, David J. Rothman. 2019. Physician activism in American politics: The opposition to the Price nomination. PLOS ONE 14(6): e0215802.
  • Mark A. Earnest; Shale L. Wong; Steven G. Federico. 2010. “Perspective: Physician Advocacy: What Is It and How Do We Do It?” Academic Medicine 85 (1): 63.
  • Russell L. Gruen; Eric G. Campbell; David Blumenthal. 2006. “Public Roles of U.S. Physicians: Community Participation, Political Involvement, and Collective Advocacy.” JAMA 296 (20): 2467–75.